Brief: Gubra And Camurus Enter Into Collaboration And License Agreement
16/12/2025 10:33
Dec 16 (Reuters) - Gubra A/S GUBRA.CO: GUBRA AND CAMURUS ENTER INTO A COLLABORATION AND LICENSE AGREEMENT TO DEVELOP A LONG-ACTING TREATMENT FOR HYPOPARATHYROIDISM UNDER AGREEMENT, CAMURUS WILL DEVELOP AND COMMERCIALIZE PRODUCT AND GUBRA HAS OPTION TO CO-FINANCE PRODUCT THROUGH DEVELOPMENT GUBRA WILL RECEIVE TIERED ROYALTIES SCALED TO ITS CHOSEN LEVEL OF FINANCIAL PARTICIPATION. Source text: ID:nMFNbX0S65 Further company coverage: GUBRA.CO (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))